← Back to home
Comparison · Analytics

admiralneuro vs metatools

A side-by-side editorial comparison of admiralneuro and metatools — release velocity, themes, recent moves, and the top alternatives to consider.

Shared themes:pharmaverse

admiralneuro vs metatools: at a glance

Featureadmiralneurometatools
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themespharmaverse, cdisc-adam, neurology, pet-imagingpharmaverse, sdtm, adam, clinical-trials
Last editorial update1h ago49m ago
WebsiteVisit →Visit →

What is admiralneuro?

admiralneuro is widening from Alzheimer's PET into general nervous-system findings.

The package launched in September 2025 with amyloid and tau PET analysis for Alzheimer's studies — centiloid computation, five neuro datasets, and ADAPET/ADTPET template programs. The February 2026 update is tagged twice on the same day, 0.2.0 and 0.2.1 carrying the same notes, and adds olfactory testing plus a nervous-system findings template.

Read the full admiralneuro trajectory →

What is metatools?

SDTM supplemental-qualifier merging got sturdier, then the package went quiet for two years.

metatools provides the utilities that build and check SDTM and ADaM datasets against their metadata in the pharmaverse. The 0.1.6 release in July 2024 is the substantive one: combine_supp() learned to handle zero-row supplemental data, to refuse QNAM columns already present in the source, and to route multiple QNAM values to the same IDVAR, alongside enhanced controlled-terminology checks and record-uniqueness verification. Nothing has shipped since.

Read the full metatools trajectory →

admiralneuro vs metatools: editorial side-by-side

A
admiralneuro
ANALYTICS
0.0

admiralneuro is widening from Alzheimer's PET into general nervous-system findings.

◆ Current state

The package launched in September 2025 with amyloid and tau PET analysis for Alzheimer's studies — centiloid computation, five neuro datasets, and ADAPET/ADTPET template programs. The February 2026 update is tagged twice on the same day, 0.2.0 and 0.2.1 carrying the same notes, and adds olfactory testing plus a nervous-system findings template.

◆ Where it's heading

Development is moving from one disease area toward a general neuro toolkit: UPSIT smell-identification percentiles now sit alongside PET quantitation, and the ADNV template covers nervous-system findings broadly rather than PET specifically. Internal SDTM test data was retired in favour of pharmaversesdtm, tying the package more tightly to the shared pharmaverse data layer.

◆ Prediction

More assessment-specific compute functions on the UPSIT pattern are the obvious next step, each arriving with a vignette and a template program alongside it.

M
metatools
ANALYTICS
0.0

SDTM supplemental-qualifier merging got sturdier, then the package went quiet for two years.

◆ Current state

metatools provides the utilities that build and check SDTM and ADaM datasets against their metadata in the pharmaverse. The 0.1.6 release in July 2024 is the substantive one: combine_supp() learned to handle zero-row supplemental data, to refuse QNAM columns already present in the source, and to route multiple QNAM values to the same IDVAR, alongside enhanced controlled-terminology checks and record-uniqueness verification. Nothing has shipped since.

◆ Where it's heading

The package's development has been concentrated on one function, combine_supp(), which is where the messy realities of supplemental qualifiers surface — whitespace in join keys, empty supp datasets, colliding names. 0.1.6 also drew three first-time contributors, which is the healthiest signal in the history, but no release has followed. Sibling packages have meanwhile been dropping metatools as a dependency.

◆ Prediction

Without a release in two years the package looks stable rather than active; the plausible trigger is a controlled-terminology or dplyr change that forces the checks to be updated.

Alternatives to admiralneuro and metatools

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either admiralneuro or metatools.

See all admiralneuro alternatives → · See all metatools alternatives →

Recent activity from admiralneuro and metatools

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 5mo agoadmiralneuroPre-release tag superseded the same day by 0.2.1
  2. 5mo agoadmiralneuroUPSIT olfactory scoring and an ADNV template
  3. 11mo agoadmiralneuroInitial release with amyloid and tau PET workflows
  4. 2y agometatoolscombine_supp() hardened; controlled-terminology checks extended
  5. 3y agometatools0.1.4 Update to dplyr and small bug fixes
  6. 4y agometatools0.1.1 first CRAN release

Frequently asked questions

What is the difference between admiralneuro and metatools?

Both compete on the same themes — pharmaverse — within Analytics. admiralneuro and metatools are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is admiralneuro better than metatools?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. admiralneuro and metatools are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to admiralneuro?

Top admiralneuro alternatives in Analytics are ranked by recent ship velocity. Browse the "admiralneuro alternatives" section above for the current picks, or visit /alternatives/admiralneuro for the full list with editorial commentary on each.

What are the best alternatives to metatools?

Top metatools alternatives in Analytics are ranked by recent ship velocity. Browse the "metatools alternatives" section above for the current picks, or visit /alternatives/metatools for the full list with editorial commentary on each.